Alkosign Limited (BOM:543453)
India · Delayed Price · Currency is INR 75.49
+6.69 (9.72%)
At close: Jan 20, 2026
Alkosign Revenue
Alkosign had revenue of 263.38M INR in the half year ending September 30, 2025, with 23.91% growth. This brings the company's revenue in the last twelve months to 499.69M, up 18.04% year-over-year. In the fiscal year ending March 31, 2025, Alkosign had annual revenue of 515.31M with 44.40% growth.
Revenue (ttm)
499.69M
Revenue Growth
+18.04%
P/S Ratio
2.24
Revenue / Employee
6.09M
Employees
82
Market Cap
1.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 515.31M | 158.44M | 44.40% |
| Mar 31, 2024 | 356.87M | 143.09M | 66.94% |
| Mar 31, 2023 | 213.78M | 112.17M | 110.40% |
| Mar 31, 2022 | 101.61M | -30.91M | -23.33% |
| Mar 31, 2021 | 132.51M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indian Sucrose | 4.87B |
| Shivam Chemicals | 2.61B |
| Rungta Irrigation | 2.15B |
| Optimus Finance | 1.67B |
| Sanmit Infra | 1.27B |
| Resonance Specialties | 852.48M |
| Raaj Medisafe India | 732.21M |
| Raja Bahadur International | 277.95M |